C.K. McWhorter Continues Goldman Sachs Communications: Potential Strong Partnership Ties
C.K. McWhorter Continues Goldman Sachs Communications: Potential Strong Partnership Ties
April 11, 2024 09:26 ET | McWhorter Foundation
C.K. McWhorter Continues Goldman Sachs Communications: Potential Strong Partnership Ties
C.K. McWhorter Opens Conversations With Goldman Sachs A Historic Odyssey In Finance.
C.K. McWhorter Opens Conversations With Goldman Sachs A Historic Odyssey In Finance
March 26, 2024 10:29 ET | McWhorter Foundation
C.K. McWhorter Opens Conversations With Goldman Sachs A Historic Odyssey In Finance.
zerohash_brand_logo-set_october-2022_wordmark_black.png
Zero Hash Honored by Goldman Sachs for Entrepreneurship
October 18, 2023 09:00 ET | Zero Hash
CHICAGO, Oct. 18, 2023 (GLOBE NEWSWIRE) -- Today, Goldman Sachs (NYSE:GS) is recognizing Zero Hash Founder and CEO, Edward Woodford as one of the Most Exceptional Entrepreneurs of 2023 at its...
Recursion to Partici
Recursion to Participate in Upcoming Investor Conference
August 01, 2023 08:30 ET | Recursion Pharmaceuticals
SALT LAKE CITY, Aug. 01, 2023 (GLOBE NEWSWIRE) -- Recursion (NASDAQ: RXRX), a leading clinical stage TechBio company decoding biology to industrialize drug discovery, today announced its...
myriad_S_stacked.png
Myriad Genetics to Participate in Goldman Sachs Healthcare Conference
June 07, 2023 16:05 ET | Myriad Genetics, Inc.
SALT LAKE CITY, June 07, 2023 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc., (NASDAQ: MYGN), a leader in genetic testing and precision medicine, today announced Paul J. Diaz, president and CEO, will...
INN_LogoTag_RGB.jpg
InnovAge Announces Participation at the 44th Annual Goldman Sachs Global Healthcare Conference
June 05, 2023 08:00 ET | InnovAge
DENVER, June 05, 2023 (GLOBE NEWSWIRE) -- InnovAge Holding Corp. (“InnovAge” or the “Company”) (Nasdaq: INNV), an industry leader in providing comprehensive healthcare programs to frail seniors...
Recursion to Partici
Recursion to Participate in Upcoming Investor Conferences
June 01, 2023 08:30 ET | Recursion Pharmaceuticals
SALT LAKE CITY, June 01, 2023 (GLOBE NEWSWIRE) -- Recursion (NASDAQ: RXRX), a clinical stage TechBio company decoding biology to industrialize drug discovery, today announced its participation in...
RevolutionLogo.png
Revolution Medicines to Participate in TD Cowen 4th Annual Oncology Innovation Summit
May 24, 2023 16:05 ET | Revolution Medicines, Inc.
REDWOOD CITY, Calif., May 24, 2023 (GLOBE NEWSWIRE) -- Revolution Medicines, Inc. (Nasdaq: RVMD), a clinical-stage oncology company developing targeted therapies for RAS-addicted cancers, today...
Micron logo_blue_RGB.jpg
Micron Technology Announces Upcoming Investor Events
May 04, 2023 16:01 ET | Micron Technology, Inc.
BOISE, Idaho, May 04, 2023 (GLOBE NEWSWIRE) -- Micron Technology, Inc. (Nasdaq: MU), announced today that company executives will participate in fireside chats at the following investor events: ...
July 30, 2021 - ROSEN LOGO.jpg
ROSEN, GLOBAL INVESTOR COUNSEL, Encourages The Goldman Sachs Group, Inc. Investors to Inquire About Securities Class Action Investigation – GS
February 14, 2023 20:00 ET | The Rosen Law Firm PA
NEW YORK, Feb. 14, 2023 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of The Goldman...